To determine at what stage of tumorigenesis the GFAP+ enteric glia might be exerting their pro-tumorigenic effect, we depleted these cells at different points during tumor development: starting at week four, when dysplastic lesions were evident, or starting at week ten, after tumors were established. Here, GFAP is linked to neoplasm.